Encompass Health

RSS Feed
Encompass Health is a provider of healthcare services, providing both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. The company's inpatient rehabilitation hospitals provide specialized rehabilitative care across an array of diagnoses and deliver patient care services. The company's home health agencies provide home care services such as skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The company also provides hospice services such as pain control and symptom management, and emotional and spiritual support to terminally ill patients and their families.
  • TickerEHC
  • ISINUS29261A1007
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
Free Trial
EHC Encompass Healt... (Health Care)

Encompass Health Corp: 1 director sold/sold after exercising options

A director at Encompass Health Corp sold/sold after exercising options 8,589 shares at 81.400USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under...

March 9, 2021 1 EN
Free Trial
EHC Encompass Healt... (Health Care)

With a more favourable environment, ENCOMPASS HEALTH improves to Sligh...

ENCOMPASS HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 22, 2020, the closing price was USD 82.36 and its potential was estimated at USD 93.80.

December 23, 2020 6 EN
Free Trial
EHC Encompass Healt... (Health Care)

Encompass Health Corp: 1 director sold/sold after exercising options

A director at Encompass Health Corp sold/sold after exercising options 8,589 shares at 81.400USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under...

March 9, 2021 1 EN
Free Trial
EHC Encompass Healt... (Health Care)

With a more favourable environment, ENCOMPASS HEALTH improves to Sligh...

ENCOMPASS HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 22, 2020, the closing price was USD 82.36 and its potential was estimated at USD 93.80.

December 23, 2020 6 EN
Free Trial
EHC Encompass Healt... (Health Care)

Encompass Health Corp: 1 director sold/sold after exercising options

A director at Encompass Health Corp sold/sold after exercising options 8,589 shares at 81.400USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under...

March 9, 2021 1 EN
Free Trial
EHC Encompass Healt... (Health Care)

With a more favourable environment, ENCOMPASS HEALTH improves to Sligh...

ENCOMPASS HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 22, 2020, the closing price was USD 82.36 and its potential was estimated at USD 93.80.

December 23, 2020 6 EN
Free Trial
EHC Encompass Healt... (Health Care)

Encompass Health Corp: 1 director sold/sold after exercising options

A director at Encompass Health Corp sold/sold after exercising options 8,589 shares at 81.400USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under...

March 9, 2021 1 EN
Free Trial
EHC Encompass Healt... (Health Care)

With a more favourable environment, ENCOMPASS HEALTH improves to Sligh...

ENCOMPASS HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 22, 2020, the closing price was USD 82.36 and its potential was estimated at USD 93.80.

December 23, 2020 6 EN
Free Trial
EHC Encompass Healt... (Health Care)

Encompass Health Corp: 1 director sold/sold after exercising options

A director at Encompass Health Corp sold/sold after exercising options 8,589 shares at 81.400USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under...

March 9, 2021 1 EN
Free Trial
EHC Encompass Healt... (Health Care)

With a more favourable environment, ENCOMPASS HEALTH improves to Sligh...

ENCOMPASS HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 22, 2020, the closing price was USD 82.36 and its potential was estimated at USD 93.80.

December 23, 2020 6 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch